--- schema_version: "secwatch.filing_event.v1" accession: "0001513162-22-000140" form_type: "8-K" ticker: "BMRA" cik: "0000073290" company_name: "BIOMERICA INC" filed_at: "2022-12-09T23:59:59+00:00" generated_at: "2026-06-21T07:05:27.542957+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.25 calibrated_materiality_score: 0.15 confidence: "high" source: SEC EDGAR --- # Biomerica shareholders elect all five director nominees; approve 2022 Stock Incentive Plan ## Summary - Zackary Irani elected with 4,584,648 votes; all nominees received majority of votes cast. - Advisory say-on-pay passed with 4,570,514 votes for (44,365 against, 36,548 abstain). - Stockholders voted for every-one-year frequency for future say-on-pay votes (3,466,478 in favor). - Ratification of Haskell & White LLP as auditor for FY ending May 31, 2023 approved (7,047,314 for). - 2022 Stock Incentive Plan approved with 2,395,243 votes for, 2,227,813 against, 28,371 abstain. ## SEC filing metadata - accession: 0001513162-22-000140 - form_type: 8-K - ticker: BMRA - cik: 0000073290 - company_name: BIOMERICA INC - filed_at: 2022-12-09T23:59:59+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.25 - calibrated_materiality_score: 0.15 - confidence: high - sec_items: 5.07 - EDGAR index: https://www.sec.gov/Archives/edgar/data/73290/000151316222000140/0001513162-22-000140-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/73290/000151316222000140/bmra-20221207.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001513162-22-000140 - JSON: https://secwatch.observer/filing/0001513162-22-000140.json - Plain text: https://secwatch.observer/filing/0001513162-22-000140.txt ## Key facts - Shareholder Votes BIOMERICA INC shareholders approved Advisory vote on named executive officers' compensation at the 2022-12-07 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2022-12-07 source text: Item 5.07 Submission of Matters to a Vote of Security Holders. Biomerica, Inc. (the “Company”) held its 2022 annual meeting (the “2022 Annual Meeting”) of stockholders of the Company on December 7, 2022, at its corporate headquarter in Irvine, California. As of October 14, 2022, the record date for the 2022 Annual Meeting, the Company had 13,474,338 shares of its common stock outstanding and entitled to vote, of which 7,126,662 shares of the Company’s common stock were present in person or represented by proxy and entitled to vote at the 2022 Annual Meeting. The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the 2022 Annual Meeting. Proposal No. 1 : The Company’s stockholders elected each of the five nominees named below to serve on the Company’s Board of Directors until t he next annual meeting of stockholders of the Company and until his or her successor has been elected and qualified or until his or evidence_url: https://www.sec.gov/Archives/edgar/data/73290/000151316222000140/0001513162-22-000140-index.htm - Shareholder Votes BIOMERICA INC shareholders approved Ratification and approval of the 2022 Stock Incentive Plan at the 2022-12-07 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2022-12-07 source text: Item 5.07 Submission of Matters to a Vote of Security Holders. Biomerica, Inc. (the “Company”) held its 2022 annual meeting (the “2022 Annual Meeting”) of stockholders of the Company on December 7, 2022, at its corporate headquarter in Irvine, California. As of October 14, 2022, the record date for the 2022 Annual Meeting, the Company had 13,474,338 shares of its common stock outstanding and entitled to vote, of which 7,126,662 shares of the Company’s common stock were present in person or represented by proxy and entitled to vote at the 2022 Annual Meeting. The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the 2022 Annual Meeting. Proposal No. 1 : The Company’s stockholders elected each of the five nominees named below to serve on the Company’s Board of Directors until t he next annual meeting of stockholders of the Company and until his or her successor has been elected and qualified or until his or evidence_url: https://www.sec.gov/Archives/edgar/data/73290/000151316222000140/0001513162-22-000140-index.htm - Shareholder Votes BIOMERICA INC shareholders approved Election of five nominees to the Board of Directors at the 2022-12-07 meeting. - Proposal: director election - Outcome: passed - Meeting: 2022-12-07 source text: Item 5.07 Submission of Matters to a Vote of Security Holders. Biomerica, Inc. (the “Company”) held its 2022 annual meeting (the “2022 Annual Meeting”) of stockholders of the Company on December 7, 2022, at its corporate headquarter in Irvine, California. As of October 14, 2022, the record date for the 2022 Annual Meeting, the Company had 13,474,338 shares of its common stock outstanding and entitled to vote, of which 7,126,662 shares of the Company’s common stock were present in person or represented by proxy and entitled to vote at the 2022 Annual Meeting. The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the 2022 Annual Meeting. Proposal No. 1 : The Company’s stockholders elected each of the five nominees named below to serve on the Company’s Board of Directors until t he next annual meeting of stockholders of the Company and until his or her successor has been elected and qualified or until his or evidence_url: https://www.sec.gov/Archives/edgar/data/73290/000151316222000140/0001513162-22-000140-index.htm - Shareholder Votes BIOMERICA INC shareholders approved Ratification of appointment of Haskell & White LLP as independent auditor at the 2022-12-07 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2022-12-07 source text: Item 5.07 Submission of Matters to a Vote of Security Holders. Biomerica, Inc. (the “Company”) held its 2022 annual meeting (the “2022 Annual Meeting”) of stockholders of the Company on December 7, 2022, at its corporate headquarter in Irvine, California. As of October 14, 2022, the record date for the 2022 Annual Meeting, the Company had 13,474,338 shares of its common stock outstanding and entitled to vote, of which 7,126,662 shares of the Company’s common stock were present in person or represented by proxy and entitled to vote at the 2022 Annual Meeting. The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the 2022 Annual Meeting. Proposal No. 1 : The Company’s stockholders elected each of the five nominees named below to serve on the Company’s Board of Directors until t he next annual meeting of stockholders of the Company and until his or her successor has been elected and qualified or until his or evidence_url: https://www.sec.gov/Archives/edgar/data/73290/000151316222000140/0001513162-22-000140-index.htm - Shareholder Votes BIOMERICA INC shareholders approved Frequency of future advisory votes on executive compensation (every one year) at the 2022-12-07 meeting. - Proposal: say on pay frequency - Outcome: passed - Meeting: 2022-12-07 source text: Item 5.07 Submission of Matters to a Vote of Security Holders. Biomerica, Inc. (the “Company”) held its 2022 annual meeting (the “2022 Annual Meeting”) of stockholders of the Company on December 7, 2022, at its corporate headquarter in Irvine, California. As of October 14, 2022, the record date for the 2022 Annual Meeting, the Company had 13,474,338 shares of its common stock outstanding and entitled to vote, of which 7,126,662 shares of the Company’s common stock were present in person or represented by proxy and entitled to vote at the 2022 Annual Meeting. The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the 2022 Annual Meeting. Proposal No. 1 : The Company’s stockholders elected each of the five nominees named below to serve on the Company’s Board of Directors until t he next annual meeting of stockholders of the Company and until his or her successor has been elected and qualified or until his or evidence_url: https://www.sec.gov/Archives/edgar/data/73290/000151316222000140/0001513162-22-000140-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.